{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "6392228", "DateCompleted": {"Year": "1985", "Month": "02", "Day": "19"}, "DateRevised": {"Year": "2017", "Month": "12", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0161-7567", "JournalIssue": {"Volume": "57", "Issue": "6", "PubDate": {"Year": "1984", "Month": "Dec"}}, "Title": "Journal of applied physiology: respiratory, environmental and exercise physiology", "ISOAbbreviation": "J Appl Physiol Respir Environ Exerc Physiol"}, "ArticleTitle": "Ozone-induced changes in muscarinic bronchial reactivity by different testing methods.", "Pagination": {"StartPage": "1783", "EndPage": "1789", "MedlinePgn": "1783-9"}, "Abstract": {"AbstractText": ["We examined the effect of ozone (O3) on muscarinic bronchial reactivity in the guinea pig and compared reactivity determined by two different routes of agonist delivery. Reactivity before and from 4 h to 2 days after O3 exposure (3.0 ppm, 2 h) was determined by measuring specific airway resistance upon administration of intravenous acetylcholine and/or aerosolized methacholine challenge in 34 unanesthetized, spontaneously breathing animals. Before exposure, we observed more gradual and reproducible results to intravenous agonist. After exposure, hyperreactivity to parenteral agonist occurred consistently, but not to inhaled agonist. Hyperreactivity demonstrable by either route was similar in magnitude and time course within 14 h of exposure. Two days later, hyperreactivity to inhaled agonist had remitted; that to intravenous drug persisted. Our results indicate that variability in the occurrence and time course of O3-induced hyperreactivity to inhaled agonist may be a consequence of the technique employed. The consistent occurrence of hyperreactivity after O3 to parenteral agonist suggests mechanisms other than airway mucosal hyperpermeability are responsible for this hyperreactivity."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Roum", "ForeName": "J H", "Initials": "JH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Murlas", "ForeName": "C", "Initials": "C"}], "GrantList": [{"GrantID": "HL-00624", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-29020", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Appl Physiol Respir Environ Exerc Physiol", "NlmUniqueID": "7801242", "ISSNLinking": "0161-7567"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Aerosols"}, {"RegistryNumber": "0", "NameOfSubstance": "Methacholine Compounds"}, {"RegistryNumber": "0W5ETF9M2K", "NameOfSubstance": "Methacholine Chloride"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "7T101UWZ5W", "NameOfSubstance": "Muscarine"}, {"RegistryNumber": "N9YNS0M02X", "NameOfSubstance": "Acetylcholine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acetylcholine"}, {"QualifierName": [], "DescriptorName": "Aerosols"}, {"QualifierName": ["drug effects"], "DescriptorName": "Airway Resistance"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Bronchi"}, {"QualifierName": [], "DescriptorName": "Bronchial Provocation Tests"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Bronchial Spasm"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": [], "DescriptorName": "Infusions, Parenteral"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Methacholine Chloride"}, {"QualifierName": [], "DescriptorName": "Methacholine Compounds"}, {"QualifierName": ["physiology"], "DescriptorName": "Muscarine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Time Factors"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1984", "Month": "12", "Day": "1"}, {"Year": "1984", "Month": "12", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1984", "Month": "12", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["6392228", "10.1152/jappl.1984.57.6.1783"]}}], "PubmedBookArticle": []}